ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
0.4151
-0.0026 (-0.62%)
At close: Oct 31, 2025, 4:00 PM EDT
0.4312
+0.0161 (3.88%)
After-hours: Oct 31, 2025, 7:43 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $22.34 million as of October 31, 2025. Its market cap has decreased by -26.68% in one year.
Market Cap
22.34M
Enterprise Value
17.79M
1-Year Change
-26.68%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $22.34M, an increase of 2.36%. That is a compound annual growth rate of 0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 22.48M | -27.45% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | 24.02M | -34.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 236.67B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |